查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
治療用呼吸系統設備的世界市場規模:各產品，各用途，各最終用途，產業分析，地區預測，成長可能性，COVID-19影響的分析，競爭市場佔有率與預測(2022年～2030年)
市場調查報告書
商品編碼
1132583

治療用呼吸系統設備的世界市場規模:各產品，各用途，各最終用途，產業分析，地區預測，成長可能性，COVID-19影響的分析，競爭市場佔有率與預測(2022年～2030年)

Therapeutic Respiratory Devices Market Size By Product, By Application, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030
出版日期: | 出版商: Global Market Insights Inc. | 英文 330 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球治療用呼吸系統設備市場，預計至2030年記錄大幅度的成長。產業的擴大，起因於免疫力低可能容易有呼吸系統問題的老年人口增加。

本報告提供全球治療用呼吸系統設備市場相關調查分析，產業的考察，市場區隔分析，地區分析，競爭情形等資訊。

目錄

第1章 調查手法和範圍

第2章 摘要整理

第3章 治療用呼吸系統設備產業的考察

  • 產業市場區隔
  • 產業形勢(2017年～2030年)
  • 產業的影響要素
    • 成長促進因素
    • 產業的潛在的風險、課題
  • 成長可能性分析
    • 各產品
    • 各用途
    • 各最終用途
  • 技術形勢
  • 法規形勢
    • 美國
    • 歐洲
  • COVID-19影響的分析
  • 波特的五力分析
  • 競爭情形(2021年)
    • 企業矩陣分析(2021年)
  • 大環境分析

第4章 治療用呼吸系統設備市場:各產品

  • 主要的市場區隔趨勢
  • 陽壓呼吸器(PAP)設備
    • 市場規模:各地區(2017年～2030年)
    • 持續性陽壓呼吸器(CPAP)設備
    • 自動滴定陽壓呼吸器(APAP)設備
    • 雙階陽壓呼吸器(BiPAP)設備
  • 氧氣濃縮機
    • 市場規模:各地區(2017年～2030年)
    • 固定式氧氣濃縮機
    • 便攜式氧氣濃縮機
  • 人工呼吸器
    • 市場規模:各地區(2017年～2030年)
    • 成人用人工呼吸器
    • 新生兒用人工呼吸器
  • 吸入器
    • 市場規模:各地區(2017年～2030年)
    • 定量噴霧吸入器(MDI)
    • 乾粉吸入劑(DPI)
    • 緩霧吸入器(SMI)
  • 噴霧器
    • 市場規模:各地區(2017年～2030年)
    • 壓縮機式噴霧器
    • 活塞式手持噴霧器
    • 超音波式噴霧器
  • 加濕器
    • 市場規模:各地區(2017年～2030年)
    • 加溫加濕器
    • 通行證外套型加濕器
    • 一體型加濕器
    • 內裝加濕器
    • 獨立加濕器
  • 其他

第5章 治療用呼吸系統設備市場:各用途

  • 主要的市場區隔趨勢
  • COPD
  • 阻塞型睡眠呼吸中止症
  • 氣喘
  • 呼吸窘迫症候群
  • 囊狀纖維化症
  • 其他

第6章 治療用呼吸系統設備市場:各最終用途

  • 主要的市場區隔趨勢
  • 醫院
  • 居家照護環境
  • 急救中心

第7章 治療用呼吸系統設備市場:各地區

  • 主要地區趨勢
  • 北美
    • 市場規模:各國(2017年～2030年)
    • 市場規模:各產品(2017年～2030年)
    • 市場規模:各用途(2017年～2030年)
    • 市場規模:各最終用途(2017年～2030年)
    • 美國
    • 加拿大
  • 歐洲
    • 市場規模:各國(2017年～2030年)
    • 市場規模:各產品(2017年～2030年)
    • 市場規模:各用途(2017年～2030年)
    • 市場規模:各最終用途(2017年～2030年)
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
  • 亞太地區
    • 市場規模:各國(2017年～2030年)
    • 市場規模:各產品(2017年～2030年)
    • 市場規模:各用途(2017年～2030年)
    • 市場規模:各最終用途(2017年～2030年)
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 南美
    • 市場規模:各國(2017年～2030年)
    • 市場規模:各產品(2017年～2030年)
    • 市場規模:各用途(2017年～2030年)
    • 市場規模:各最終用途(2017年～2030年)
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東、非洲
    • 市場規模:各國(2017年～2030年)
    • 市場規模:各產品(2017年～2030年)
    • 市場規模:各用途(2017年～2030年)
    • 市場規模:各最終用途(2017年～2030年)
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第8章 企業簡介

  • 競爭儀表板(2021年)
  • Breas Medical AB
  • Dragerwerk AG & Co. KGaA
  • Fisher & Paykel Healthcare Limited
  • GE Healthcare
  • Hamilton Medical
  • Hill-Rom Services Inc. (Baxter)
  • ICU Medical, Inc.
  • Invacare Corporation
  • Koninklijke Philips N.V.
  • Medtronic
  • ResMed
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • VYAIRE MEDICAL, INC.
簡介目錄
Product Code: 696

The global therapeutic respiratory devices market is anticipated to register considerable growth through 2030. The industry expansion can be attributed to the rising elderly population which is prone to respiratory problems due to weakened immune systems. To that end, the instances of respiratory-related infections have also risen, leading to lung cancer, COPD, and asthma. The high rate of respiratory deaths is likely to drive product sales in the projected timeline. Also, the availability of advanced medical devices to minimize the severity of every person's medical condition will foster market growth.

The high costs associated with the treatment of respiratory diseases may be a key factor hindering the industry expansion. As per a study, asthma results in approximately 500,000 deaths annually and over 1,300 deaths daily. Rising caseloads of respiratory diseases and increased intensity of illness have raised treatment costs. Eventually, it increases the burden on healthcare units due to direct and indirect expenses.

Based on product, the industry is segmented into positive airway pressure (PAP) devices, oxygen concentrators, ventilators, inhalers, humidifiers, and nebulizers. The ventilators segment registered over USD 4 billion in 2021, owing to technological advancements in product design and the surge in the geriatric population. Additionally, improved capabilities of ventilation technologies for lung injury prevention and fewer treatment times are likely to foster the growth of the segment.

On the basis of application, the industry is classified into COPD, asthma, obstructive sleep apnea, cystic fibrosis, and respiratory distress syndrome. The asthma segment held over 28% market share in 2021, owing to the introduction of advanced medications including inhalers and nebulizers. According to the data from the Asthma and Allergy Foundation of America, nearly 25 million people are susceptible to asthma in the U.S., which is equivalent to 1 in 13 people. Additionally, the average mortality from asthma is 11 in the U.S. daily. In 2020, 4,145 patients died of asthma, which increases the need for advanced asthma medications.

Based on end-use, the industry is categorized into hospitals, homecare settings, and emergency centers. The industry size from the homecare settings segment is flourishing at a considerable rate, owing to the adoption of improved treatment procedures that require minimal intervention from doctors. In addition, the increased psychological comfort and favorable environment facilitate the patient.

On the regional front, the industry is classified into North America, Europe, Asia Pacific, Latin America, and MEA. Latin America is expected to grow at over 4% CAGR, owing to the increased instances of respiratory problems in the region. Additionally, the adoption of the latest treatment modules for treating such ailments is likely to foster product sales in the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Methodology
  • 1.2 Market definitions
  • 1.3 Forecast parameters
  • 1.4 Data sources
    • 1.4.1 Secondary
      • 1.4.1.1 Paid sources
      • 1.4.1.2 Unpaid sources
    • 1.4.2 Primary

Chapter 2 Executive Summary

  • 2.1 Therapeutic respiratory devices industry 360 degree synopsis, 2017 - 2030
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 Application trends
    • 2.1.4 End-use trends
    • 2.1.5 Regional trends

Chapter 3 Therapeutic Respiratory Devices Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2030 (USD Million)
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Rising prevalence of respiratory diseases in developing countries
      • 3.3.1.2 Increasing geriatric population globally
      • 3.3.1.3 Technological innovation in developed countries
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Lack of patient compliance
      • 3.3.2.2 Cost burden of respiratory diseases
  • 3.4 Growth potential analysis
    • 3.4.1 By product
    • 3.4.2 By application
    • 3.4.3 By end-use
  • 3.5 Technology landscape
  • 3.6 Regulatory landscape
    • 3.6.1 U.S.
    • 3.6.2 Europe
  • 3.7 COVID- 19 impact analysis
  • 3.8 Porter's analysis
  • 3.9 Competitive landscape, 2021
    • 3.9.1 Company matrix analysis, 2021
  • 3.10 PESTLE analysis

Chapter 4 Therapeutic Respiratory Devices Market, By Product

  • 4.1 Key segment trends
  • 4.2 Positive Airway Pressure (PAP) devices
    • 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.2.2 Continuous positive airway pressure (CPAP) devices
      • 4.2.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.2.3 Auto-titrating positive airway pressure (APAP) devices
      • 4.2.3.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.2.4 Bi-level positive airway pressure (BiPAP) devices
      • 4.2.4.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.3 Oxygen concentrators
    • 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.3.2 Fixed oxygen concentrators
      • 4.3.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.3.3 Portable oxygen concentrators
      • 4.3.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.4 Ventilators
    • 4.4.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.4.2 Adult ventilators
      • 4.4.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.4.3 Neonatal ventilators
      • 4.4.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.5 Inhalers
    • 4.5.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.5.2 Metered dose inhaler (MDI)
      • 4.5.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.5.3 Dry powder inhaler (DPI)
      • 4.5.3.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.5.4 Soft mist inhaler (SMI)
      • 4.5.4.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.6 Nebulizers
    • 4.6.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.6.2 Compressor-based nebulizers
      • 4.6.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.6.3 Piston-based hand-held nebulizers
      • 4.6.3.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.6.4 Ultrasonic nebulizers
      • 4.6.4.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.7 Humidifiers
    • 4.7.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.7.2 Heated humidifiers
      • 4.7.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.7.3 Passover humidifiers
      • 4.7.3.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.7.4 Integrated humidifiers
      • 4.7.4.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.7.5 Built-in humidifiers
      • 4.7.5.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.7.6 Standalone humidifiers
      • 4.7.6.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.8 Others
    • 4.8.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 5 Therapeutic Respiratory Devices Market, By Application

  • 5.1 Key segment trends
  • 5.2 COPD
    • 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.3 Obstructive sleep apnea
    • 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.4 Asthma
    • 5.4.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.5 Respiratory distress syndrome
    • 5.5.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.6 Cystic fibrosis
    • 5.6.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.7 Others
    • 5.7.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 6 Therapeutic Respiratory Devices Market, By End-use

  • 6.1 Key segment trends
  • 6.2 Hospitals
    • 6.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 6.3 Homecare settings
    • 6.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 6.4 Emergency centers
    • 6.4.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 7 Therapeutic Respiratory Devices Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.2.2 Market size, by product, 2017 - 2030 (USD Million)
      • 7.2.2.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
      • 7.2.2.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
      • 7.2.2.3 Market size, by ventilators, 2017 - 2030 (USD Million)
      • 7.2.2.4 Market size, by inhalers, 2017 - 2030 (USD Million)
      • 7.2.2.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
      • 7.2.2.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
    • 7.2.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.2.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.2.5 U.S.
      • 7.2.5.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.2.5.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.2.5.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.2.5.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.2.5.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.2.5.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.2.5.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.2.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.2.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.2.6 Canada
      • 7.2.6.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.2.6.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.2.6.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.2.6.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.2.6.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.2.6.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.2.6.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.2.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.2.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.3.2 Market size, by product, 2017 - 2030 (USD Million)
      • 7.3.2.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
      • 7.3.2.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
      • 7.3.2.3 Market size, by ventilators, 2017 - 2030 (USD Million)
      • 7.3.2.4 Market size, by inhalers, 2017 - 2030 (USD Million)
      • 7.3.2.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
      • 7.3.2.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
    • 7.3.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.3.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.5 Germany
      • 7.3.5.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.3.5.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.3.5.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.3.5.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.3.5.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.3.5.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.3.5.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.3.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.6 UK
      • 7.3.6.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.3.6.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.3.6.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.3.6.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.3.6.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.3.6.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.3.6.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.3.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.7 France
      • 7.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.3.7.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.3.7.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.3.7.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.3.7.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.3.7.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.3.7.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.3.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.8 Italy
      • 7.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.3.8.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.3.8.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.3.8.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.3.8.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.3.8.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.3.8.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.3.8.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.8.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.9 Spain
      • 7.3.9.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.3.9.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.3.9.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.3.9.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.3.9.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.3.9.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.3.9.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.3.9.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.9.3 Market size, by end-use, 2017 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.4.2 Market size, by product, 2017 - 2030 (USD Million)
      • 7.4.2.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
      • 7.4.2.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
      • 7.4.2.3 Market size, by ventilators, 2017 - 2030 (USD Million)
      • 7.4.2.4 Market size, by inhalers, 2017 - 2030 (USD Million)
      • 7.4.2.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
      • 7.4.2.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
    • 7.4.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.4.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.5 China
      • 7.4.5.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.4.5.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.4.5.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.4.5.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.4.5.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.4.5.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.4.5.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.4.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.6 Japan
      • 7.4.6.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.4.6.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.4.6.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.4.6.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.4.6.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.4.6.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.4.6.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.4.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.7 India
      • 7.4.7.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.4.7.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.4.7.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.4.7.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.4.7.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.4.7.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.4.7.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.4.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.8 Australia
      • 7.4.8.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.4.8.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.4.8.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.4.8.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.4.8.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.4.8.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.4.8.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.4.8.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.8.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.9 South Korea
      • 7.4.9.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.4.9.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.4.9.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.4.9.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.4.9.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.4.9.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.4.9.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.4.9.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.9.3 Market size, by end-use, 2017 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.5.2 Market size, by product, 2017 - 2030 (USD Million)
      • 7.5.2.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
      • 7.5.2.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
      • 7.5.2.3 Market size, by ventilators, 2017 - 2030 (USD Million)
      • 7.5.2.4 Market size, by inhalers, 2017 - 2030 (USD Million)
      • 7.5.2.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
      • 7.5.2.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
    • 7.5.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.5.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.5.5 Brazil
      • 7.5.5.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.5.5.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.5.5.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.5.5.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.5.5.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.5.5.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.5.5.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.5.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.5.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.5.6 Mexico
      • 7.5.6.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.5.6.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.5.6.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.5.6.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.5.6.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.5.6.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.5.6.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.5.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.5.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.5.7 Argentina
      • 7.5.7.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.5.7.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.5.7.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.5.7.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.5.7.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.5.7.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.5.7.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.5.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.5.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
  • 7.6 Middle East & Africa
    • 7.6.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.6.2 Market size, by product, 2017 - 2030 (USD Million)
      • 7.6.2.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
      • 7.6.2.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
      • 7.6.2.3 Market size, by ventilators, 2017 - 2030 (USD Million)
      • 7.6.2.4 Market size, by inhalers, 2017 - 2030 (USD Million)
      • 7.6.2.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
      • 7.6.2.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
    • 7.6.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.6.5 South Africa
      • 7.6.5.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.6.5.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.6.5.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.6.5.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.6.5.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.6.5.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.6.5.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.6.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.6.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.6.6 Saudi Arabia
      • 7.6.6.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.6.6.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.6.6.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.6.6.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.6.6.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.6.6.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.6.6.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.6.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.6.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.6.7 UAE
      • 7.6.7.1 Market size, by product, 2017 - 2030 (USD Million)
        • 7.6.7.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
        • 7.6.7.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
        • 7.6.7.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
        • 7.6.7.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
        • 7.6.7.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
        • 7.6.7.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
      • 7.6.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.6.7.3 Market size, by end-use, 2017 - 2030 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Strategy dashboard, 2021
  • 8.2 Breas Medical AB
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Product landscape
    • 8.2.4 Strategic outlook
    • 8.2.5 Swot analysis
  • 8.3 Dragerwerk AG & Co. KGaA
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Product landscape
    • 8.3.4 Strategic outlook
    • 8.3.5 Swot analysis
  • 8.4 Fisher & Paykel Healthcare Limited
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Product landscape
    • 8.4.4 Strategic outlook
    • 8.4.5 Swot analysis
  • 8.5 GE Healthcare
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Product landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 Swot analysis
  • 8.6 Hamilton Medical
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Product landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 Swot analysis
  • 8.7 Hill-Rom Services Inc. (Baxter)
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Product landscape
    • 8.7.4 Strategic outlook
    • 8.7.5 Swot analysis
  • 8.8 ICU Medical, Inc.
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Product landscape
    • 8.8.4 Strategic outlook
    • 8.8.5 Swot analysis
  • 8.9 Invacare Corporation
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Product landscape
    • 8.9.4 Strategic outlook
    • 8.9.5 Swot analysis
  • 8.10 Koninklijke Philips N.V.
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Product landscape
    • 8.10.4 Strategic outlook
    • 8.10.5 Swot analysis
  • 8.11 Medtronic
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Product landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 Swot analysis
  • 8.12 ResMed
    • 8.12.1 Business overview
    • 8.12.2 Financial data
    • 8.12.3 Product landscape
    • 8.12.4 Strategic outlook
    • 8.12.5 Swot analysis
  • 8.13 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 8.13.1 Business overview
    • 8.13.2 Financial data
    • 8.13.3 Product landscape
    • 8.13.4 Strategic outlook
    • 8.13.5 Swot analysis
  • 8.14 VYAIRE MEDICAL, INC.
    • 8.14.1 Business overview
    • 8.14.2 Financial data
    • 8.14.3 Product landscape
    • 8.14.4 Strategic outlook
    • 8.14.5 Swot analysis